Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

59.50
+1.382.37%
Post-market: 59.550.0500+0.08%19:59 EDT
Volume:2.45M
Turnover:149.15M
Market Cap:5.75B
PE:-12.50
High:62.54
Open:59.72
Low:58.89
Close:58.12
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:1.25
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:3.29
PE(LYR):-9.20

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 05, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 04, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

Major Issues Report

Form 8-K - Current report
Feb 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities